{"title":"纯前列腺小细胞癌:一种罕见的肿瘤。","authors":"Simone Albisinni, Cosimo De Nunzio, Andrea Tubaro","doi":"10.4103/0970-1591.94964","DOIUrl":null,"url":null,"abstract":"<p><p>PURE SMALL CELL CARCINOMA OF THE PROSTATE IS A RARE AND AGGRESSIVE NEOPLASM, WITH ONLY FEW CASES DESCRIBED IN LITERATURE AND POOR PROGNOSIS: mean survival is 5 months. We report the case of a patient with this disease, with special attention to the evolution of neuroendocrine markers as Chromogranine A and neuron-specific enolase during the progression of the tumor, evaluating their possible role in staging and follow up.</p>","PeriodicalId":520644,"journal":{"name":"Indian journal of urology : IJU : journal of the Urological Society of India","volume":" ","pages":"89-91"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/65/8a/IJU-28-89.PMC3339794.pdf","citationCount":"5","resultStr":"{\"title\":\"Pure small cell carcinoma of the prostate: A rare tumor.\",\"authors\":\"Simone Albisinni, Cosimo De Nunzio, Andrea Tubaro\",\"doi\":\"10.4103/0970-1591.94964\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>PURE SMALL CELL CARCINOMA OF THE PROSTATE IS A RARE AND AGGRESSIVE NEOPLASM, WITH ONLY FEW CASES DESCRIBED IN LITERATURE AND POOR PROGNOSIS: mean survival is 5 months. We report the case of a patient with this disease, with special attention to the evolution of neuroendocrine markers as Chromogranine A and neuron-specific enolase during the progression of the tumor, evaluating their possible role in staging and follow up.</p>\",\"PeriodicalId\":520644,\"journal\":{\"name\":\"Indian journal of urology : IJU : journal of the Urological Society of India\",\"volume\":\" \",\"pages\":\"89-91\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/65/8a/IJU-28-89.PMC3339794.pdf\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Indian journal of urology : IJU : journal of the Urological Society of India\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/0970-1591.94964\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian journal of urology : IJU : journal of the Urological Society of India","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/0970-1591.94964","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Pure small cell carcinoma of the prostate: A rare tumor.
PURE SMALL CELL CARCINOMA OF THE PROSTATE IS A RARE AND AGGRESSIVE NEOPLASM, WITH ONLY FEW CASES DESCRIBED IN LITERATURE AND POOR PROGNOSIS: mean survival is 5 months. We report the case of a patient with this disease, with special attention to the evolution of neuroendocrine markers as Chromogranine A and neuron-specific enolase during the progression of the tumor, evaluating their possible role in staging and follow up.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
